IIT RESEARCH INSTITUTE - FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS
Key Details
Description
FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS
Context & Analysis
On Nov 21, 2025, Department of Health and Human Services obligated $512,266 to IIT RESEARCH INSTITUTE for first-in-class small molecule candidate ncgc72 (cd206 agonist) for immunologically cold solid organ cancers. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 4 offers received. Performance is located in CHICAGO, IL. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
Stay Updated
Get notified about new opportunities matching your interests.